Pharmacovigilance And Drug Safety Software Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

 Focused on real-world business use, this report highlights what’s changing in the pharmacovigilance and drug safety software market and what companies should prepare for next.





Pharmacovigilance And Drug Safety Software Market Analysis & Forecast: 2025-2029

The pharmacovigilance and drug safety software market size has grown rapidly in recent years. It will grow from $2.26 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing the demand for pharmacovigilance and drug safety software.



The pharmacovigilance and drug safety software market size is expected to see rapid growth in the next few years. It will grow to $4.09 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to rising adverse drug reaction incidences and the globalization of pharmacovigilance, growing incidence of adverse drug reactions, increased complexity in drug safety regulations, increase in the development of new drugs and therapies, increasing incidence of adverse drug reactions (ADRs), rising number of adverse drug reactions. Major trends in the forecast period include automation and AI integration, cloud-based solutions, technological innovation, advancement in technologies, and increasing healthcare digitalization.



Get your free sample today:

Pharmacovigilance Software Market 2025



What Are The Factors Driving The Pharmacovigilance And Drug Safety Software Market?

The growing demand for personalized medicine is expected to propel the growth of the pharmacovigilance and drug safety software market going forward. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare decisions and treatments to the individual characteristics of each patient. The growing demand for personalized medicine is due to several factors, such as improved treatment outcomes, a focus on prevention and early detection, and cost-effectiveness. Pharmacovigilance and drug safety software are essential to the success of personalized medicine. By incorporating pharmacogenetics, real-time data analysis, post-marketing surveillance, and personalized medication information, these tools improve the safety and efficacy of individualized treatments while supporting robust risk management strategies and addressing ethical considerations. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the pharmacovigilance and drug safety software market.



What Segments Are Covered In The Pharmacovigilance And Drug Safety Software Market Report?

The pharmacovigilance and drug safety software market covered in this report is segmented –



1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users



Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools



Emerging Trends And Strategic Opportunities In The Pharmacovigilance And Drug Safety Software Market

Major companies operating in the pharmacovigilance and drug safety software market are developing innovative technologies, such as cloud-based data lake platforms, to enhance patient safety, monitor adverse events more effectively, and improve regulatory compliance in clinical trials and post-market surveillance of medical devices. A cloud-based data lake platform is a scalable, centralized storage system that allows organizations to store, manage, and analyze vast amounts of structured and unstructured data. It provides real-time data access and supports advanced analytics and AI/ML workloads. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched CorEvidence, an innovative proprietary cloud-based data lake platform designed to enhance pharmacovigilance processes within clinical research registries. This platform aims to optimize case processing and safety data management, particularly for post-authorization safety studies.



Which Are The Major Players Operating In The Global Pharmacovigilance And Drug Safety Software Market?

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies



View the full pharmacovigilance and drug safety software market report here:

Pharmacovigilance Software Market 2025



Pharmacovigilance And Drug Safety Software Market Regional Insights:

North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.



#Contact Us:#



The Business Research Company



Market Research Reports



Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267



Email: info@tbrc.info





#Follow Us On:#



LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Future of the Antifungals Market: Insights, Developments, and Strategic Overview

Image
 Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the antifungals industry. Antifungals Market Valuation Forecast: What Will The Market Be Worth By 2025? The antifungals market size has grown strongly in recent years. It will grow from $27.16 billion in 2024 to $29.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education. The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, ...
Read more

Polybutylene Terephthalate (PBT) Market Analysis 2025 – Supporting High-Stakes Corporate Planning

Image
 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Polybutylene Terephthalate (PBT) industry. What is the projected value of the polybutylene terephthalate (pbt) market by 2029? The polybutylene terephthalate (PBT) market size has grown strongly in recent years. It will grow from $2.5 billion in 2024 to $2.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to adoption in new industries, global economic conditions, electrical vehicle adoption, consumer goods and textile applications, advancements in material properties. The polybutylene terephthalate (PBT) market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued focus on...
Read more

Zero Trust Security Market Report 2025 – Insights for Decision Makers and Market Strategists

Image
 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the zero trust security industry by 2029? The zero trust security market size has grown rapidly in recent years. It will grow from $38.45 billion in 2024 to $45.05 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to cyber threat landscape, legacy security challenges, digital transformation, remote workforce trend, data privacy concerns. The zero trust security market size is expected to see exponential growth in the next few years. It will grow to $99.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to threat intelligence integration, user-centric security approach, data volume growth, business co...
Read more